Up to 160 jobs are at risk at a US pharmaceutical firm which is to close one of its factories in Dublin by the end of 2015.
The closure of Bristol-Myers Squibb’s manufacturing facility in Cruiserath will, according to the company, impact 130 employees.
A further 30 will be affected by the closure of one of the parts of another of its facilities in Swords. That whole plant currently employs 320 people.
A Bristol-Myers Squibb spokeswoman said the decision to close the Cruiserath facility “reflects the changing market demand for a number of products manufactured at the site”.
She said the closure of part of the Swords operation was “part of ongoing optimisation in the company’s manufacturing network.
However, she added that Swords will remain a key supplier of bulk pharmaceuticals.
Susan Hynes, the company’s general manager of API operations here, said: “The company is working with IDA Ireland to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland.”
Siptu said it represents 20 of the people who are to be made redundant. It said it had sought an urgent meeting with the company management to explore any possible ways to minimise the job losses.
Siptu organiser Michelle Quinn said: “We are led to believe that these redundancies will be voluntary and the offer will be made across the site. This announcement came as a shock to the workers and their families.”
© Irish Examiner Ltd. All rights reserved